[go: up one dir, main page]

BRPI0921058A2 - éteres alquilciclo-hexílicos de di-hidrotetra-azabenzoazulenos - Google Patents

éteres alquilciclo-hexílicos de di-hidrotetra-azabenzoazulenos

Info

Publication number
BRPI0921058A2
BRPI0921058A2 BRPI0921058A BRPI0921058A BRPI0921058A2 BR PI0921058 A2 BRPI0921058 A2 BR PI0921058A2 BR PI0921058 A BRPI0921058 A BR PI0921058A BR PI0921058 A BRPI0921058 A BR PI0921058A BR PI0921058 A2 BRPI0921058 A2 BR PI0921058A2
Authority
BR
Brazil
Prior art keywords
dihydrotetraazabenzoazulenes
alkylcyclohexyl
ethers
dihydrotetraazabenzoazulenes alkylcyclohexyl
alkylcyclohexyl ethers
Prior art date
Application number
BRPI0921058A
Other languages
English (en)
Inventor
Schnider Patrick
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0921058A2 publication Critical patent/BRPI0921058A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/55171,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Luminescent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BRPI0921058A 2008-11-18 2009-11-09 éteres alquilciclo-hexílicos de di-hidrotetra-azabenzoazulenos BRPI0921058A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08169348 2008-11-18
PCT/EP2009/064804 WO2010057795A1 (en) 2008-11-18 2009-11-09 Alkylcyclohexylethers of dihydrotetraazabenzoazulenes

Publications (1)

Publication Number Publication Date
BRPI0921058A2 true BRPI0921058A2 (pt) 2018-10-16

Family

ID=41398220

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921058A BRPI0921058A2 (pt) 2008-11-18 2009-11-09 éteres alquilciclo-hexílicos de di-hidrotetra-azabenzoazulenos

Country Status (25)

Country Link
US (1) US8642590B2 (pt)
EP (1) EP2358714B1 (pt)
JP (1) JP5384659B2 (pt)
KR (1) KR101385433B1 (pt)
CN (1) CN102216304B (pt)
AR (1) AR074354A1 (pt)
AU (1) AU2009317386B2 (pt)
BR (1) BRPI0921058A2 (pt)
CA (1) CA2739900C (pt)
CL (1) CL2011001129A1 (pt)
CY (1) CY1113692T1 (pt)
DK (1) DK2358714T3 (pt)
ES (1) ES2391374T3 (pt)
HR (1) HRP20120816T1 (pt)
IL (1) IL212119A (pt)
MX (1) MX2011005119A (pt)
PE (1) PE20110590A1 (pt)
PL (1) PL2358714T3 (pt)
PT (1) PT2358714E (pt)
RU (1) RU2510397C2 (pt)
SG (1) SG171742A1 (pt)
SI (1) SI2358714T1 (pt)
TW (1) TWI389911B (pt)
WO (1) WO2010057795A1 (pt)
ZA (1) ZA201102604B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009315754B2 (en) 2008-11-13 2013-08-15 F. Hoffmann-La Roche Ag Spiro-5,6-dihydro-4H-2,3,5,10b-tetraaza-benzo[e]azulenes
BRPI0921058A2 (pt) 2008-11-18 2018-10-16 Hoffmann La Roche éteres alquilciclo-hexílicos de di-hidrotetra-azabenzoazulenos
CA2743976C (en) * 2008-11-28 2017-02-21 Patrick Schnider Arylcyclohexylethers of dihydrotetraazabenzoazulenes for use as vasopressin via receptor antagonists
US8420633B2 (en) 2010-03-31 2013-04-16 Hoffmann-La Roche Inc. Aryl-cyclohexyl-tetraazabenzo[e]azulenes
US8461151B2 (en) 2010-04-13 2013-06-11 Hoffmann-La Roche Inc. Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes
US8492376B2 (en) 2010-04-21 2013-07-23 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8481528B2 (en) 2010-04-26 2013-07-09 Hoffmann-La Roche Inc. Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8513238B2 (en) 2010-05-10 2013-08-20 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes
US8828989B2 (en) * 2011-09-26 2014-09-09 Hoffmann-La Roche Inc. Oxy-cyclohexyl-4H,6H-5-oxa-2,3,10b-triaza-benzo[E]azulenes as V1A antagonists
CA2847095A1 (en) * 2011-10-05 2013-04-11 F. Hoffmann-La Roche Ag Cyclohexyl-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenes as v1a antagonists
KR102384629B1 (ko) * 2013-12-05 2022-04-11 에프. 호프만-라 로슈 아게 트랜스-8-클로로-5-메틸-1-[4-(피리딘-2-일옥시)-사이클로헥실]-5,6-다이하이드로-4H-2,3,5,10b-테트라아자-벤조[e]아줄렌 및 그의 결정 형태의 합성
WO2017191117A1 (en) 2016-05-03 2017-11-09 Bayer Pharma Aktiengesellschaft V1a receptor antagonists for use in the treatment of renal diseases
CN108329051B (zh) * 2017-07-04 2020-09-18 中国科学院金属研究所 一种超高孔隙率和低坯体收缩率Y2SiO5多孔陶瓷的制备方法
EP4082535A1 (en) 2017-12-08 2022-11-02 F. Hoffmann-La Roche AG Pharmaceutical formulation

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521173A (en) 1995-01-17 1996-05-28 American Home Products Corporation Tricyclic benzazepine vasopressin antagonists
US7138393B2 (en) * 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
KR100771184B1 (ko) * 1999-01-19 2007-10-29 오르토-맥네일 파마슈티칼, 인코퍼레이티드 바소프레신 수용체 길항제로서의 트리사이클릭 벤조디아제핀
TWI239333B (en) 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
GB0303852D0 (en) 2003-02-19 2003-03-26 Pfizer Ltd Triazole compounds useful in therapy
CA2539426C (en) 2003-09-17 2012-07-10 Janssen Pharmaceutica, Nv Fused heterocyclic compounds
GB0400700D0 (en) * 2004-01-13 2004-02-18 Pfizer Ltd Compounds useful in therapy
JP4085178B2 (ja) * 2004-05-17 2008-05-14 アステラス製薬株式会社 縮合ベンズアゼピン誘導体の新規製造法
KR100840852B1 (ko) 2004-05-25 2008-06-23 화이자 프로덕츠 인크. 테트라아자벤조[e]아줄렌 유도체 및 이의 유사체
CN1950374A (zh) * 2004-05-25 2007-04-18 辉瑞产品公司 四氮杂苯并[e]甘菊环衍生物及其类似物
EP1632494A1 (en) 2004-08-24 2006-03-08 Ferring B.V. Vasopressin v1a antagonists
CA2578370A1 (en) * 2004-08-25 2006-03-02 Pfizer Inc. Triazolobenzodiazepines and their use as vasopressin antagonists
CA2600763A1 (en) 2005-03-15 2006-09-21 F. Hoffmann-La Roche Ag Use of 2 -anilino - 3 , 4 -dihydro - quinazolines as 5ht5a receptor antagonists
WO2006114706A1 (en) 2005-04-26 2006-11-02 Pfizer Limited Triazole derivatives as vasopressin antagonists
EP1885713A1 (en) 2005-05-18 2008-02-13 Pfizer Limited 1, 2, 4 -triazole derivatives as vasopressin antagonists
MX2009007411A (es) 2007-01-12 2009-07-17 Hoffmann La Roche Derivados de espiropiperidina-glicinamida.
BRPI0921058A2 (pt) 2008-11-18 2018-10-16 Hoffmann La Roche éteres alquilciclo-hexílicos de di-hidrotetra-azabenzoazulenos
US8420633B2 (en) * 2010-03-31 2013-04-16 Hoffmann-La Roche Inc. Aryl-cyclohexyl-tetraazabenzo[e]azulenes
US8461151B2 (en) * 2010-04-13 2013-06-11 Hoffmann-La Roche Inc. Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes
US8492376B2 (en) * 2010-04-21 2013-07-23 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8481528B2 (en) * 2010-04-26 2013-07-09 Hoffmann-La Roche Inc. Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8513238B2 (en) 2010-05-10 2013-08-20 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes

Also Published As

Publication number Publication date
CY1113692T1 (el) 2016-06-22
HRP20120816T1 (hr) 2012-11-30
TWI389911B (zh) 2013-03-21
US20100125066A1 (en) 2010-05-20
PE20110590A1 (es) 2011-08-31
PT2358714E (pt) 2012-10-09
CN102216304A (zh) 2011-10-12
WO2010057795A1 (en) 2010-05-27
CN102216304B (zh) 2014-07-09
DK2358714T3 (da) 2012-08-20
IL212119A0 (en) 2011-06-30
RU2510397C2 (ru) 2014-03-27
KR20110074594A (ko) 2011-06-30
RU2011121438A (ru) 2012-12-27
US8642590B2 (en) 2014-02-04
EP2358714B1 (en) 2012-08-01
SI2358714T1 (sl) 2012-11-30
ES2391374T3 (es) 2012-11-23
JP2012508269A (ja) 2012-04-05
MX2011005119A (es) 2011-05-30
EP2358714A1 (en) 2011-08-24
AR074354A1 (es) 2011-01-12
AU2009317386A1 (en) 2010-05-27
AU2009317386B2 (en) 2013-07-25
CA2739900C (en) 2016-11-08
ZA201102604B (en) 2012-09-26
CA2739900A1 (en) 2010-05-27
JP5384659B2 (ja) 2014-01-08
TW201031666A (en) 2010-09-01
CL2011001129A1 (es) 2011-10-07
KR101385433B1 (ko) 2014-04-14
SG171742A1 (en) 2011-07-28
IL212119A (en) 2014-12-31
PL2358714T3 (pl) 2012-12-31

Similar Documents

Publication Publication Date Title
NL301152I2 (nl) satralizumab
NL300922I2 (nl) dupilumab
BRPI0921058A2 (pt) éteres alquilciclo-hexílicos de di-hidrotetra-azabenzoazulenos
BRPI1016172A2 (pt) éteres diarílicos
SMT201600307B (it) Composizione liposomiale
BRPI0911989A2 (pt) uniões micélicas
BRPI0921327A2 (pt) Combinação de herbicida-protetor
EP2364114A4 (en) An intervertebral ABSTANDSHALTER
BRPI1013588A2 (pt) composição
DK3444343T3 (da) Polypeptider
DE112009004078A5 (de) Getriebeeinheit
FI20085383A0 (fi) Matonpesulaitteisto
BRPI1015474A2 (pt) composição
FIC20240018I1 (fi) Vamoroloni
DK2336132T3 (da) Morpholinpurinderivat
DK2837348T3 (da) Kryokirurgiske fremgangsmåder
BRPI0920858A2 (pt) caixa de câmbio
EP2505644A4 (en) REGULATION COMPOSITION OF THE ATMOSPHERE
EP2519755A4 (en) FRONT SURFACE CLUTCH
DE112009000197T8 (de) Schiermittelzusammensetzung
BRPI0907522A2 (pt) biarlamidas
FR2926856B1 (fr) Compresseur de turboreacteur
BRPI0922728A2 (pt) combinação de herbicida-antídoto
BRPI1005318A2 (pt) composição
EP2376295A4 (en) LATERAL WALL SHEAR DECOUPLING LAYER

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2539 DE 03-09-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.